Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Rang in Aktien #7357
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Aktienkurs
$42.98
Zuletzt synchronisiert: 2024-06-21
Marktkapitalisierung
$1.62B
Veränderung (1 Tag)
0.01%
Veränderung (1 Jahr)
0.00%
Land
IL
Handel Taro Pharmaceutical Industries Ltd. (TARO)

Kategorie

EPS für Taro Pharmaceutical Industries Ltd. (TARO)
EPS zum March 2024 TTM: $1.44
Laut den aktuellen Finanzberichten und dem Aktienkurs von Taro Pharmaceutical Industries Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) $1.44. Am Ende des Jahres 2023 betrug das EPS $0.68 ein Rückgang im Vergleich zu dem EPS von 2022, das $1.55 betrug.
EPS-Verlauf von Taro Pharmaceutical Industries Ltd. von 1999 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $1.44 0.70%
2024 $1.43 110.29%
2023 $0.68 -56.13%
2022 $1.55 -114.78%
2021 $-10.49 -265.20%
2020 $6.35 -12.17%
2019 $7.23 37.45%
2018 $5.26 -52.40%
2017 $11.05 -12.44%
2016 $12.62 11.58%
2015 $11.31 38.94%
2014 $8.14 36.58%
2013 $5.96 462.26%
2012 $1.06 -33.33%
2010 $1.59 -45.36%
2009 $2.91 273.08%
2008 $0.78 -21.21%
2007 $0.99 -135.11%
2006 $-2.82 -1,584.21%
2005 $0.19 -50.00%
2004 $0.38 -82.08%
2003 $2.12 36.77%
2002 $1.55 39.64%
2001 $1.11 136.17%
2000 $0.47 67.86%
1999 $0.28 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber